New: Introducing the Finviz Crypto Map

Learn More

Stocks Pivot Lower as ISM Data, Tariff Drama Weighs

By Patrick Martin | August 05, 2025, 11:49 AM

Wall Street lost its footing today after a confident open, with all three major indexes slipping into the red amid the latest tariff updates. The Dow Jones Industrial Average (DJIA) is off by 107 points, weighed down by Caterpillar (CAT) earnings. The S&P 500 and Nasdaq Composite (IXIC) are also firmly lower after the ISM Services Index came in flat for July, disappointing investors and overshadowing a stellar earnings report from Palantir Technologies (PLTR)

Continue reading for more on today's market, including:

  • Pfizer stock trying to lift up the Dow.
  • Restaurant stock dinged by earnings miss.
  • Plus, call traders blitz Top Pick; AXON surges higher; and a fintech stock struggling.

MMC Stats Aug 5

Options traders are blitzing Lemonade Inc (NYSE:LMND) stock today, after the insurance company's second-quarter earnings exceeded expectations. At last check, over 28,000 calls have changed hands, volume that's 11 times he average intraday amount and almost triple the number of puts traded. The weekly 8/8 50-strike call is the most popular, with new positions being opened there as well as the September 50 call. Lemonade stock -- a top pick for the next six months -- is up almost 30% year-to-date, back above its year-to-date breakeven level and now 187% higher year-over-year. 

Axon Enterprise Inc (NASDAQ:AXON) stock is one of the best stocks on Wall Street today, up 17.1% to trade at $872.47, after the taser maker hiked its annual revenue forecast to go with a top-line second-quarter beat. In response, five brokerages hiked their price targets, while Craig-Hallum upgraded the shares to "buy" with a $900 price target. AXON hit a record high of $885.91 out of the gate, and is 47% higher in 2025. 

AXON Stock Chart

Zebra Technologies Corp. (NASDAQ:ZBRA) stock is near the bottom of the Nasdaq today, last seen down 8.8% to trade at $311.46. The asset intelligence firm reported a second-quarter top-line beat and hiked its full-year guidance, but the shares have pivoted into the red after trading as high as $350 out of the gate this morning. ZBRA has stalled out around this area since the latter half of July, and is now down nearly 21% in 2025.

Mentioned In This Article

Latest News